IMR OpenIR
Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma
其他题名Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma
Xu Wen1; Sun Jin1; Zhang TingTing1; Ma Bo1; Cui ShengMiao1; Chen DaWei1; He ZhongGui1
2006
发表期刊ACTA PHARMACOLOGICA SINICA
ISSN1671-4083
卷号27期号:12页码:1642-1646
摘要Aim: To study the intravenous and oral pharmacokinetic behavior of oridonin and its extent of absolute oral bioavailability in rats. Methods: Oridonin was administered to rats via iv (5,10 and 15 mg/kg), po (20,40 and 80 mg/kg) or ip administration (10 mg/kg). The concentrations of oridonin in rat plasma were determined by a high performance liquid chromatography with electrospray ionization mass spec-trometric detection (HPLC/ESI-MS) method and the pharmacokinetic parameters were determined by non-compartmental analysis. Results: The plasma concentration of oridonin after intravenous administration decreased polyexponentially, and the pharmacokinetic parameters of oridonin were dose-independent within the examined range. Oridonin was absorbed rapidly after oral gavage with a t(max) of less than 15 min; the extent of absolute bioavailability of oridonin following oral administration was 4.32%, 4.58% and 10.8%. The extent of absolute bioavailability of oridonin following intraperitoneal administration was 12.6%. Conclusion: First order rate pharmacokinetics were observed for oridonin within the range of iv doses, while the extent of absolute oral bioavailability was rather low and dose-dependent. The low and dose-dependent extent of oral bioavailability may be due to the saturation of first-pass effects.
其他摘要Aim: To study the intravenous and oral pharmacokinetic behavior of oridonin and its extent of absolute oral bioavailability in rats. Methods: Oridonin was administered to rats via iv (5, 10 and 15 mg/kg), po (20, 40 and 80 mg/kg) or ip administration (10 mg/kg). The concentrations of oridonin in rat plasma were determined by a high performance liquid chromatography with electrospray ionization mass spectrometric detection (HPLC/ESI-MS) method and the pharmacokinetic parameters were determined by non-compartmental analysis. Results: The plasma concentration of oridonin after intravenous administration decreased polyexponentially, and the pharmacokinetic parameters of oridonin were dose-independent within the examined range. Oridonin was absorbed rapidly after oral gavage with a tmax of less than 15 min; the extent of absolute bioavailability of oridonin following oral administration was 4.32%, 4.58% and 10.8%. The extent of absolute bioavailability of oridonin following intraperitoneal administration was 12.6%. Conclusion: First order rate pharmacokinetics were observed for oridonin within the range of iv doses, while the extent of absolute oral bioavailability was rather low and dose- dependent. The low and dose-dependent extent of oral bioavailability may be due to the saturation of first-pass effects.
关键词RABDOSIA-RUBESCENS SIGNAL PATHWAYS CELLS oridonin pharmacokinetics intravenous oral bioavailability intraperitoneal injections rats
收录类别CSCD
语种英语
CSCD记录号CSCD:2618176
引用统计
文献类型期刊论文
条目标识符http://ir.imr.ac.cn/handle/321006/150909
专题中国科学院金属研究所
作者单位1.中国科学院金属研究所
2.Guangdong Pharmaceut University
推荐引用方式
GB/T 7714
Xu Wen,Sun Jin,Zhang TingTing,et al. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma[J]. ACTA PHARMACOLOGICA SINICA,2006,27(12):1642-1646.
APA Xu Wen.,Sun Jin.,Zhang TingTing.,Ma Bo.,Cui ShengMiao.,...&He ZhongGui.(2006).Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.ACTA PHARMACOLOGICA SINICA,27(12),1642-1646.
MLA Xu Wen,et al."Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma".ACTA PHARMACOLOGICA SINICA 27.12(2006):1642-1646.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xu Wen]的文章
[Sun Jin]的文章
[Zhang TingTing]的文章
百度学术
百度学术中相似的文章
[Xu Wen]的文章
[Sun Jin]的文章
[Zhang TingTing]的文章
必应学术
必应学术中相似的文章
[Xu Wen]的文章
[Sun Jin]的文章
[Zhang TingTing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。